Transperineal Ultrasound to Assess the Progress of Labour
NCT ID: NCT02430038
Last Updated: 2024-10-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
584 participants
OBSERVATIONAL
2015-04-30
2018-01-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Ultrasound Based Prediction of Delivery Mode
NCT04635410
Prediction of Preterm Delivery with Serial Cervical Length Measurements After Threatened Preterm Labor
NCT05044143
Prediction of Delivery With Transperineal Ultrasound in Women With Prolonged Labour. Multicentre Study
NCT01610453
Detection of Preterm Labour by Cervical Length
NCT04104984
Ultrasound Prediction of Prolonged Labour
NCT00915148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
AIMS:
This study aims to firstly assess the effectiveness and acceptability of transperineal ultrasound in women presenting between 24 and 42 weeks gestation in comparison with digital vaginal examination (VE). Secondly, in all term (37-42 weeks) labouring women, investigators aim to create an ultrasound based labour record, "a sonopartogram" and from this develop a predictive model for the outcome of labour.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acceptability
To assess acceptability of intervention. Some patients from this group also participated in the other groups.
No interventions assigned to this group
Feasibility
Is it possible for ultrasound to measure labour parameters, where vaginal examinations are best avoided e.g. vaginismus or contraindicated (PPROM) with controls. Some patients from this group also participated in the other groups.
No interventions assigned to this group
Predictive Model
Nulliparous term labouring women with cephalic presentation. Some patients from this group also participated in the other groups.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-44
* Cephalic
* Singleton pregnancies
* Nulliparous
* Multiparous (excluded for the term predictive model group)
* Multiple pregnancies (excluded for the term predictive model group)
* Established (Active) phase of labour (included for the term predictive model group) o Clinician opinion that patient is in the established phase of labour according to the current NICE guidelines
Exclusion Criteria
* Imminent iatrogenic intention to deliver
* Life threatening maternal or fetal compromise needing immediate medical attention and/or delivery
* Women who in the opinion of the researcher by virtue of language or learning impairment would be unable to give fully informed consent to the study.
* Miscarriage
* Intra-uterine death
* Previous cervical surgery eg. cone biopsy, cervical cerclage. Note- Single LLETZ is not excluded.
* Non-cephalic presentations
* Multiple pregnancies (for the term predictive model group)
* Multiparous patients (for the term predictive model group)
* Not in established labour (for the term predictive model group)
18 Years
44 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College Healthcare NHS Trust
OTHER
KU Leuven
OTHER
Norwegian University of Science and Technology
OTHER
British Medical Association
OTHER
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Lees, MD MRCOG
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College Healthcare NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14HH2428
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.